Valeant Pharma (NYSE: VRX) is recently up 21c to $23.43 in the premarket on Sequoia Fund, the longtime and once the largest investor in Valeant exiting the investment last month. July call option implied volatility is at 82, August is at 86; compared to its 52-week range of 29 to